Methods for predicting drug efficacy in patients afflicted with hypertension

Details for Australian Patent Application No. 2004245762 (hide)

Owner deCODE genetics ehf.

Inventors Hakonarson, Hakon

Agent Davies Collison Cave

Pub. Number AU-B-2004245762

PCT Pub. Number WO2004/108960

Priority 60/477,087 09.06.03 US

Filing date 4 June 2004

Wipo publication date 16 December 2004

Acceptance publication date 28 February 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

15 December 2005 PCT application entered the National Phase

  PCT publication WO2004/108960 Priority application(s): WO2004/108960

28 February 2008 Application Accepted

  Published as AU-B-2004245762

26 June 2008 Standard Patent Sealed

7 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004245764-Offshore production system with drilling/workover rig

2004245761-Methods and compositions for diagnosing and treating disorders involving angiogenesis